comprehensive -WSS

comprehensive

author：explore 2025-09-03 09:22:00 - browse：14172

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello, friends! I’m in San Francisco for the STAT Breakthrough Summit. Later today, I’ll be “fireside chatting” with Cytokinetics CEO Robert Blum. It’s not too late to join us virtually. Check out details here.

It’s a travel-shortened week for me, so in this newsletter, I decided to dive deep into PDS Biotech and its experimental drug for head and neck cancer. PDS is what I’d call a biotech cult stock.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： STAT Summit: Meghan O’Rourke on making chronic illness visible

focus

WSS

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Many immigrants are left out of maternal health programs

Teacher posts viral 'school supply rant' with advice for parents

How AI can help patients find reliable information about doctors

What AstraZeneca

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

knowledge

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

Jerome Adams on the need for new antivirals for Covid

STAT Summit: The economic case for universal basic health care

How to save PrEP access — and even expand it

FDA clears Verve to begin U.S. study of gene

ChatGPT in medicine: STAT answers readers' burning questions

Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says

Bright Health sells Medicare Advantage business to Molina

Campaign finance charge dropped from case against Sam Bankman

How to save PrEP access — and even expand it

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

explore

Why a market frenzy over new weight loss drugs defies logic

Teacher posts viral 'school supply rant' with advice for parents

American TikTok star stuck in Dubai for months following rental car altercation

STAT Summit: Ending the crisis of Black deaths in the U.S.

STAT Readout: Friday, Oct. 20 biotech updates

House GOP plan to stem drug shortages differs from Democrats’

leisure time

leisure time

focus

hotspot